TP53 and hepatocellular carcinoma: Interestingly, we observed that Notch3 silencing sensitized HCC cells to doxorubicin through p53 activation and identified a complex network of mutual regulations resulting in a Notch3/CG1/p53/miR-221/MDM2 axis promoting p53-sustained activation [31,86].